Nelson, Van Denburg & Campbell Wealth Management Group, LLC Novo Cure LTD Transaction History

Nelson, Van Denburg & Campbell Wealth Management Group, LLC

$2.1 Billion
Q1 2024

2 transactions

Quarter	Operation	Price Per share	shares change	shares Held	SEC Form
Q3 2021 Nov 02, 2021	SELL	$116.17 - $194.55 $6,970 - $11,673	-60 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$68.3 - $93.8 $4,098 - $5,628	60 New	60 $5,000

Others Institutions Holding NVCR

# of Institutions

277

Shares Held

73.2M

Call Options Held

1.43M

Put Options Held

832K

Vanguard Group Inc Valley Forge, PA

10M
Shares

$168 Million
0.0% of portfolio
Black Rock Inc. New York, NY

9.08M
Shares

$153 Million
0.0% of portfolio
Capital International Investors Los Angeles, CA

8.86M
Shares

$149 Million
0.03% of portfolio
State Street Corp Boston, MA

3.36M
Shares

$56.5 Million
0.0% of portfolio
Price T Rowe Associates Inc Baltimore, MD

2.38M
Shares

$40 Million
0.0% of portfolio

View Full List

About NovoCure Ltd

Ticker NVCR
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 104,950,000
Market Cap $1.76B
Description
NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...

More about NVCR

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Nelson, Van Denburg & Campbell Wealth Management Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Nelson, Van Denburg & Campbell Wealth Management Group, LLC with notifications on news.

Account